Indication
Choroidal neovascularization
Choroidal neovascularization is an ocular condition characterized by the abnormal proliferation of immature, pathological blood vessels arising from the choriocapillaris that penetrate Bruch’s membrane into the subretinal pigment epithelium or subretinal space. Read more about Choroidal neovascularization
8 drugs 8 manufacturers
Drugs that treat it
Common Choroidal neovascularization therapies.
LUCENTIS (ranibizumab)
VISUDYNE (verteporfin)
CIMERLI (ranibizumab-eqrn)
CIMERLI (ranibizumab-eqrn)
BYOOVIZ (ranibizumab-nuna)
VISUDYNE (verteporfin)
NUFYMCO (ranibizumab-leyk)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChoroidal neovascularization is an ocular condition characterized by the abnormal proliferation of immature, pathological blood vessels arising from the choriocapillaris that penetrate Bruch’s membrane into the subretinal pigment epithelium or subretinal space.
It primarily affects adults with underlying retinal disorders, serving as the hallmark of wet age-related macular degeneration and a major sight-threatening complication in pathologic myopia, ocular histoplasmosis, or inflammatory chorioretinopathies.
Clinically, these immature vessels are fragile and hyperpermeable, leading to intraretinal or subretinal exudation, hemorrhage, retinal pigment epithelial detachment, and subsequent fibrovascular scarring that causes rapid, severe loss of central visual acuity.
- nih.gov
Choroidal neovascularization is an ocular condition characterized by the abnormal proliferation of immature, pathological blood vessels arising from the choriocapillaris that penetrate Bruch’s membrane into the subretinal pigment epithelium or subretinal space Clinically, these immature vessels are fragile and hyperpermeable, leading to intraretinal or subretinal exudation, hemorrhage, retinal pigment epithelial detachment, and subsequent fibrovascular scarring that causes rapid, severe loss of ...
- nih.gov
Choroidal neovascularization is an ocular condition characterized by the abnormal proliferation of immature, pathological blood vessels arising from the choriocapillaris that penetrate Bruch’s membrane into the subretinal pigment epithelium or subretinal space Clinically, these immature vessels are fragile and hyperpermeable, leading to intraretinal or subretinal exudation, hemorrhage, retinal pigment epithelial detachment, and subsequent fibrovascular scarring that causes rapid, severe loss of ...
- nih.gov
It primarily affects adults with underlying retinal disorders, serving as the hallmark of wet age-related macular degeneration and a major sight-threatening complication in pathologic myopia, ocular histoplasmosis, or inflammatory chorioretinopathies Clinically, these immature vessels are fragile and hyperpermeable, leading to intraretinal or subretinal exudation, hemorrhage, retinal pigment epithelial detachment, and subsequent fibrovascular scarring that causes rapid, severe loss of central vi...
- nih.gov
It primarily affects adults with underlying retinal disorders, serving as the hallmark of wet age-related macular degeneration and a major sight-threatening complication in pathologic myopia, ocular histoplasmosis, or inflammatory chorioretinopathies
- aao.org
It primarily affects adults with underlying retinal disorders, serving as the hallmark of wet age-related macular degeneration and a major sight-threatening complication in pathologic myopia, ocular histoplasmosis, or inflammatory chorioretinopathies
- southeasternretina.com
Clinically, these immature vessels are fragile and hyperpermeable, leading to intraretinal or subretinal exudation, hemorrhage, retinal pigment epithelial detachment, and subsequent fibrovascular scarring that causes rapid, severe loss of central visual acuity
Personalize your experience
Follow Choroidal neovascularization and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.